Company intelligence / Profile preview

Semical

Antalya OIZ, Antalya, Turkeypmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Employees: ~25
Development stage: Commercial

Overview

Semical is a commercial-stage regenerative medicine company specializing in innovative biomaterials and medical devices for hard and soft tissue repair. Its portfolio includes CE-marked products such as intra-articular gels for osteoarthritis, wound care gels for chronic wounds, antiadhesion gels for surgery, bone grafts/implants for dental use, dermal fillers/cosmetics, and pain management creams. The company leverages advanced R&D to deliver high-quality solutions with global technology transfer capabilities[2][3][6].

Therapeutic areas: OtherDermatologyRheumatology
Modalities: BiomaterialDeviceCombination product (biomaterial + drug)Gel-based therapy
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

SEMICAL

Commercial

Indications: Knee osteoarthritis

Beyond the preview

Go deeper on Semical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Semical.

Explore the full profile